Page last updated: 2024-08-23

atomoxetine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

atomoxetine hydrochloride has been researched along with Attention Deficit and Disruptive Behavioral Disorders in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (60.00)29.6817
2010's10 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holzer, B; Lehman, R; Lopes, V1
Anagnostou, E; Baribeau, DA1
Avci, A; Bahali, K; Yalcin, O1
Alegría, AA; Brinson, H; Rubia, K1
Gardner, D; Gorman, DA; Hirsch, L; Pringsheim, T1
Hadijikoumi, I; Keen, D2
Gustafsson, PA; Hägglöf, B; Kadesjö, B; Schacht, A; Svanborg, P; Thernlund, G1
Besana, D; Bravaccio, C; Calamoneri, F; Curatolo, P; Dell'Agnello, G; Escobar, R; Mancini, F; Maschietto, D; Masi, G; Poole, L; Rossi, A; Zuddas, A1
McBurnett, K; Pfiffner, LJ1
Becker, K; D'Souza, DN; Dittmann, RW; Hazell, P; Long, A; Nikkanen, EA; Ponsler, G; Tabas, L; Tanaka, Y; Trzepacz, PT; Witcher, J1
Granger, RE; Hazell, PL; Kohn, MR; van Wyk, GW; Walton, RJ1
Dittmann, RW; Helsberg, K; Lehmann, M; Lehmkuhl, G; Schacht, A; Schneider-Fresenius, C; Wehmeier, PM1
Erder, MH; Hodgkins, PS; Lu, M; Signorovitch, J; Sikirica, V; Wu, EQ; Xie, J1
Banaschewski, T; Dittmann, RW; Kipp, L; Schacht, A; Wehmeier, PM1
Biederman, J; Michelson, D; Milton, DR; Newcorn, JH; Spencer, TJ1
Busner, J; Casat, C; Dittmann, R; Harder, D; Heiligenstein, J; Kaplan, S; Wernicke, JF; West, S1
Dworkin, N1
Barton, J; Benn, D; Danckaerts, M; Hazell, P; Johnson, M; Ladikos, A; Michelson, D; Wolańczyk, T; Yoran-Hegesh, R; Zeiner, P; Zhang, S; Zuddas, A1
Kelsberg, G; Rulon, EA; St Anna, L1
Biederman, J; Feldman, PD; Gao, H; Milton, DR; Newcorn, JH; Spencer, TJ; Witte, MM1
Faraone, SV; Hodgkins, P; Wigal, SB1
Ivanov, I; Newcorn, JH1
Bangerl, W; Friedrich, M; Kienbacher, C; Pellegrini, E; Scheidinger, H; Vesely, C; Wiesegger, G1
Bangs, ME; Coghill, DR; Danckaerts, M; Hazell, P; Hoare, P; Levine, L; Moore, RJ; Wehmeier, PM; Williams, DW1

Reviews

10 review(s) available for atomoxetine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

ArticleYear
An update on medication management of behavioral disorders in autism.
    Current psychiatry reports, 2014, Volume: 16, Issue:3

    Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Piperazines; Propylamines; Quinolones; Risperidone

2014
Brain abnormalities in attention-deficit hyperactivity disorder: a review.
    Revista de neurologia, 2014, Feb-24, Volume: 58 Suppl 1

    Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brain; Brain Mapping; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Conduct Disorder; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Methylphenidate; Nerve Net; Neuroimaging; Neuroprotective Agents; Positron-Emission Tomography; White Matter

2014
The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysi
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2015, Volume: 60, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Conduct Disorder; Humans

2015
ADHD in children and adolescents.
    BMJ clinical evidence, 2008, Oct-02, Volume: 2008

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Humans; Methylphenidate

2008
Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders.
    Postgraduate medicine, 2009, Volume: 121, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Central Nervous System Stimulants; Child; Child, Preschool; Humans; Practice Guidelines as Topic; Primary Health Care; Propylamines; Referral and Consultation

2009
How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.
    Journal of attention disorders, 2012, Volume: 16, Issue:4

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Hyperkinesis; Methylphenidate; Propylamines; Treatment Outcome

2012
ADHD in children and adolescents.
    BMJ clinical evidence, 2011, Feb-04, Volume: 2011

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Methylphenidate; Schools

2011
Clinical inquiries. What are effective treatments for oppositional defiant behaviors in adolescents?
    The Journal of family practice, 2006, Volume: 55, Issue:10

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents; Antimanic Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Comorbidity; Family Practice; Humans; Propylamines; Valproic Acid

2006
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
    Psychopharmacology, 2007, Volume: 190, Issue:1

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Personality Assessment; Propylamines; Quality of Life; Randomized Controlled Trials as Topic; Statistics as Topic

2007
[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2007, Volume: 21, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Contraindications; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Mood Disorders; Nortriptyline; Practice Guidelines as Topic; Propylamines; Randomized Controlled Trials as Topic; Tic Disorders

2007

Trials

10 trial(s) available for atomoxetine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

ArticleYear
Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Propylamines; Time Factors; Treatment Outcome; Weight Gain

2013
Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents.
    European child & adolescent psychiatry, 2009, Volume: 18, Issue:12

    Topics: Achievement; Adaptation, Psychological; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Caregivers; Child; Child Rearing; Combined Modality Therapy; Cost of Illness; Double-Blind Method; Education; Family Conflict; Female; Harm Reduction; Humans; Male; Parenting; Propylamines; Quality of Life; Self Concept; Sweden

2009
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:11

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Italy; Male; Propylamines; Psychiatric Status Rating Scales; Treatment Outcome

2009
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Attention deficit and hyperactivity disorders, 2009, Volume: 1, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Propylamines

2009
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Conduct Disorder; Disease Progression; Double-Blind Method; Female; Germany; Humans; Male; Placebos; Propylamines; Treatment Outcome

2011
Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:3

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Norepinephrine; Propylamines

2005
Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
    Journal of attention disorders, 2004, Volume: 8, Issue:2

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Norepinephrine; Propylamines; Single-Blind Method

2004
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
    European child & adolescent psychiatry, 2006, Volume: 15, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Double-Blind Method; Female; Humans; Male; Propylamines; Recurrence; Risk; Severity of Illness Index

2006
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Journal of attention disorders, 2007, Volume: 11, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Forecasting; Humans; Male; Problem Solving; Propylamines; Treatment Outcome; United States

2007
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Pediatrics, 2008, Volume: 121, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Propylamines; Treatment Outcome

2008

Other Studies

5 other study(ies) available for atomoxetine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

ArticleYear
Atomoxetine-induced wake-time teeth clenching and sleep bruxism in a child patient.
    European child & adolescent psychiatry, 2014, Volume: 23, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Propylamines; Sleep Bruxism; Treatment Outcome

2014
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorde
    Pharmacoepidemiology and drug safety, 2012, Volume: 21 Suppl 2

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comparative Effectiveness Research; Delayed-Action Preparations; Guanfacine; Humans; Outcome and Process Assessment, Health Care; Pharmacoepidemiology; Propylamines; Randomized Controlled Trials as Topic

2012
Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?
    Journal of attention disorders, 2015, Volume: 19, Issue:7

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Conduct Disorder; Double-Blind Method; Female; Humans; Male; Personality Assessment; Propylamines; Quality of Life; Reaction Time; Treatment Outcome

2015
Increased blood pressure and atomoxetine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Norepinephrine; Propylamines

2005
Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders.
    Pediatric annals, 2007, Volume: 36, Issue:9

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Benzhydryl Compounds; Central Nervous System Stimulants; Conduct Disorder; Humans; Modafinil; Neurobiology; Pediatrics; Propylamines; Psychopharmacology; Selective Serotonin Reuptake Inhibitors; United States

2007